## 

## 

||||Page|
|---|---|---|---|
|Legal and adnunistrative||information||
|Trustees'<br>annual<br>report|||2- 10|
|Independent<br>exiuuiners'||rcport||
|Statement offinancial|activities||12|
|Balance sheet|||13-14|
|Notes to the financial|statements||15-19|





|British Society|British Society|For Paediatric Endocrinology|For Paediatric Endocrinology|For Paediatric Endocrinology|and Diabetes|and Diabetes|and Diabetes|and Diabetes|||
|---|---|---|---|---|---|---|---|---|---|---|
|(A company|limited by guarantee)||||||||||
|Legal and administrative|||information||||||||
|Charity|registration||number|1135319|||||||
|Company||registration|number|07003983|||||||
|Business|address|||c/o Paediatnc|Endocnne|||Department|||
|||||EHoor Martin Wing|||||||
|||||Leeds Children's||Hospital|||||
|||||Leeds|||||||
|||||LSI 3EX|||||||
|Registered||office||c/o RWK Goodman LLP|||||||
|||||69Carter Lane|||||||
|||||London|||||||
|||||England|||||||
|||||EC4V 5EQ|||||||
|Trustees||||Dr Sabah Alvi, Treasurer|||||(resigned 9November 2023)||
|||||Dr Fiona Regan,||Treasurer|||(appointed|9 November 2023)|
|||||Dr Tabitha Randell, Chairperson|||||||
|||||Dr Melanic Kershaw,|||Secretary||||
|Accountants||||Leftley Rowe|&|Company|||||
|||||Second Hoor|||||||
|||||87Kenton Road|||||||
|||||Harrow|||||||
|||||Middlesex|||||||
|||||HA3 OAH|||||||
|Bankers||||Lloyds Bank|Pic||||||
|||||Kings Heath|||||||
|||||32 - 34 Alcester||Road South|||||
|||||Kings Heath|||||||
|||||Birmingham|||||||
|||||B147PU|||||||





## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

|||||||Unrestricted|2023|2022|
|---|---|---|---|---|---|---|---|---|
|||||||funds|Total|Total|
||||||Notes|8||s|
|Income|||||||||
|Incoming resources|from generating|||funds:|||||
|I3onattons<br>and|legacies|||||187,846|187,846|193,570|
|Income from mvestmenu||||||4,646|4,646|I '7'i|
|Total income||||||192,492|192,492|193,692|
|Expenditure|||||||||
|Costs ofgenerating|funds:||||||||
|Cost ofgenerating<br>voluntary|||income||'I|6,690|6,690|6, 166|
|Expenditure<br>on charitable||activities|||5|134,358|134,358|99,952|
|Other|||||7|6,480|6,480|6,480|
|Total expenditure||||||147,528|147.528|112,598|
|Net movement<br>in|funds|||||44,964|44,964|81,094|
|Reconciliation<br>of|funds||||||||
|Total funds brought<br>forward||||||966,983|966,983|885,889|
|Total funds carried forward||||||1,011,947|1,011,947|966.983|





## 

## 

||||||2023||2022|
|---|---|---|---|---|---|---|---|
||||Notes|||||
|Current<br>assets||||||||
|Debtors||||35,702||24,601||
|Cash at bank|and in hand|||989,566||987,02)||
|||||1,025,268||1,006,622||
|Creditors:|amounts|falling||||||
|due within|one year|||(13,321)||(39,639)||
|Net current|assets||||1,011,947||966,983|
|Net assets|||||1,011,947||966,983|
|Charity Funds||||||||
|Unrestricted|funds||14||1,011,947||966,983|
|Total funds|||||1,011,947||966,983|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

|||||Unrestricted|2023|2022|
|---|---|---|---|---|---|---|
|||||funds|Total|Total|
|Benefactor income||||146,500|146,500|151,500|
|Membership|Subscriptions|||41,346|41,346|42,070|
|||||187,846|187,846|193,570|
|Income from investments|||||||
|||||Unrestricted|2023|2022|
|||||funds|Total|Total|
|Bank interest receivable||||4,646|4,646|122|
|||||4.646|4.646|122|
|Cost ofgenerating||voluntary|income||||
|||||Unrestricted|2023|2022|
|||||funds|Total|Total|
|||||g|g|g|
|Commission||||6,690|6.690|5,106|
|Credit card fees||||||1,060|
|||||6,690|6,690|6,166|





## 

## 

## 

|5.|Expend|iture|on ch|aritable|activities|- by fund type|||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||Unrestricted|2023|2022|
|||||||||funds|Total|Total|
|||||||||f||f|
||Annual|meeting||||||87,689|87,689||
||Training|||||||20,560|20,560|25,853|
||Research|||||||26,109|26,109|74,099|
|||||||||134,358|134,358|99,952|
||Expenditure||on charitable||activities|- by activity|||||
|||||||Activities|Grant||||
|||||||undertaken|funding|Support|2023|2022|
|||||||directly|activities|costs|Total|Total|
|||||||f||f|f|f|
||Annual|meeting||||63,102|6,467|18,120|87,689||
||Tfallling|||||2,440||18,120|20,560|25,853|
||Research|||||3,669||22,440|26,109|74,099|
|||||||69,211|6.467|58,680|134,358|99,952|
|7.|Other||||||||||
|||||||||Unrestricted|2023|2022|
|||||||||funds|Total|Total|
|||||||||f||f,|
||Accountancy-||monthly|bookkeeping||||3,960|3,960|3,960|
||Accountancy||- yearly|financial|ctatemeots|||2,520|2,520|2,520|
|||||||||6,480|6,480|6,480|



## 

|||Annual|meeting|Training|Research|||
|---|---|---|---|---|---|---|---|
|||||||2023|2022|
|||||||Total|Total|
||||||f|f|f|
|Insurance|||378|378|378|1,134|1,028|
|General expenses|||148|148|148|444|402|
|Secretariat fees (including|website costs)||17,594|17,594|21,914|57,102|48,276|
||||18,120|18,120|22,440|58,680|49,706|





## 

## 

## 

## 

## 

|11.|Debtors||||||
|---|---|---|---|---|---|---|
||||||2023|2022|
||Other debtors||||24,397|24,601|
||Prepayments|and accrued income|||11,305||
||||||35,702|24,601|
|12.|Creditors: amounts||falling due||||
||within one|year|||2023|2022|
||Trade creditors|||||26,268|
||Accruals and|deferred|income||13,321|13,371|
||||||13,321|39,639|
|13.|Analysis of|net assets between funds|||||
||||||Unrestricted|Total|
||||||funds|funds|
||||||8|8|
||Fund balances|at 31 August 2023 as represented||by:|||
||Current<br>assets||||1,025268|1,025,268|
||Current<br>liabilities||||(13,321)|113,321)|
||||||1,011,947|1,011,947|





## 

## 

## 

## 

|Unrestricted|funds||||At|
|---|---|---|---|---|---|
|||Opening|Incoming|Outgoing|31August|
|||funds|resources|resources|2023|
|||||f|f|
|General reserves||966,983|192,492|tl47,528)|l,oll,947|



## 

## 

|Restricted|funds|||At|
|---|---|---|---|---|
|||Opening|31|August|
|||funds||2023|



##